Literature DB >> 25141861

Visualization of epicardial cryoablation lesions using endogenous tissue fluorescence.

Luther Swift1, Daniel A B Gil1, Rafael Jaimes1, Matthew Kay1, Marco Mercader1, Narine Sarvazyan2.   

Abstract

BACKGROUND: Percutaneous cryoballoon ablation is a commonly used procedure to treat atrial fibrillation. One of the major limitations of the procedure is the inability to directly visualize tissue damage and functional gaps between the lesions. We seek to develop an approach that will enable real-time visualization of tissue necrosis during cryo- or radiofrequency ablation procedures. METHODS AND
RESULTS: Cryoablation of either blood-perfused or saline-perfused hearts was associated with a marked decrease in nicotinamide adenine dinucleotide (NADH) fluorescence, leading to a 60% to 70% loss of signal intensity at the lesion site. The total lesion area observed on the NADH channel exhibited a strong correlation with the area identified by triphenyl tetrazolium staining (r=0.89, P<0.001). At physiological temperatures, loss of NADH became visually apparent within 26±8 s after detachment of the cryoprobe from the epicardial surface and plateaued within minutes after which the boundaries of the lesions remained stable for several hours. The loss of electrical activity within the cryoablation site exhibited a close spatial correlation with the loss of NADH (r=0.84±0.06, P<0.001). Cryoablation led to a decrease in diffuse reflectance across the entire visible spectrum, which was in stark contrast to radiofrequency ablation that markedly increased the intensity of reflected light at the lesion sites.
CONCLUSIONS: We confirmed the feasibility of using endogenous NADH fluorescence for the real-time visualization of cryoablation lesions in blood-perfused cardiac muscle preparations and revealed similarities and differences between imaging cryo- and radiofrequency ablation lesions when using ultraviolet and visible light illumination.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  ablation; atrial fibrillation arrhythmia

Mesh:

Substances:

Year:  2014        PMID: 25141861      PMCID: PMC4206680          DOI: 10.1161/CIRCEP.114.001750

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  28 in total

1.  Visualization and temporal/spatial characterization of cardiac radiofrequency ablation lesions using magnetic resonance imaging.

Authors:  A C Lardo; E R McVeigh; P Jumrussirikul; R D Berger; H Calkins; J Lima; H R Halperin
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

2.  Changes in tissue optical properties due to radio-frequency ablation of myocardium.

Authors:  J Swartling; S Pålsson; P Platonov; S B Olsson; S Andersson-Engels
Journal:  Med Biol Eng Comput       Date:  2003-07       Impact factor: 2.602

3.  Localizing and quantifying ablation lesions in the left ventricle by myocardial contrast echocardiography.

Authors:  Dirar S Khoury; Liyun Rao; Chuxiong Ding; Huabin Sun; Keith A Youker; Dorin Panescu; Sherif F Nagueh
Journal:  J Cardiovasc Electrophysiol       Date:  2004-09

4.  Experimental and analytical comparative study of optical coefficient of fresh and frozen rat tissues.

Authors:  Mohammed Mesradi; Aurelie Genoux; Vesna Cuplov; Darine Abi Haidar; Sebastien Jan; Irene Buvat; Frederic Pain
Journal:  J Biomed Opt       Date:  2013-11       Impact factor: 3.170

5.  Mechanisms of tissue destruction following cryosurgery.

Authors:  D K Whittaker
Journal:  Ann R Coll Surg Engl       Date:  1984-09       Impact factor: 1.891

6.  Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation.

Authors:  Paul Khairy; Patrick Chauvet; John Lehmann; Jean Lambert; Laurent Macle; Jean-François Tanguay; Martin G Sirois; Domenic Santoianni; Marc Dubuc
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

7.  Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation.

Authors:  C Pappone; S Rosanio; G Oreto; M Tocchi; F Gugliotta; G Vicedomini; A Salvati; C Dicandia; P Mazzone; V Santinelli; S Gulletta; S Chierchia
Journal:  Circulation       Date:  2000-11-21       Impact factor: 29.690

8.  Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies.

Authors:  Edward P Gerstenfeld; David J Callans; Sanjay Dixit; Erica Zado; Francis E Marchlinski
Journal:  J Cardiovasc Electrophysiol       Date:  2003-07

9.  Metmyoglobin reductase. Identification and purification of a reduced nicotinamide adenine dinucleotide-dependent enzyme from bovine heart which reduces metmyoglobin.

Authors:  L Hagler; R I Coppes; R H Herman
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

10.  Resumption of electrical conduction in previously isolated pulmonary veins: rationale for a different strategy?

Authors:  Kumaraswamy Nanthakumar; Vance J Plumb; Andrew E Epstein; George D Veenhuyzen; Dale Link; G Neal Kay
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

View more
  11 in total

1.  Acute enhancement of necrotic radio-frequency ablation lesions in left atrium and pulmonary vein ostia in swine model with non-contrast-enhanced T1 -weighted MRI.

Authors:  Michael A Guttman; Susumu Tao; Sarah Fink; Rick Tunin; Ehud J Schmidt; Daniel A Herzka; Henry R Halperin; Aravindan Kolandaivelu
Journal:  Magn Reson Med       Date:  2019-09-30       Impact factor: 4.668

2.  Optimization of wavelength selection for multispectral image acquisition: a case study of atrial ablation lesions.

Authors:  Huda Asfour; Shuyue Guan; Narine Muselimyan; Luther Swift; Murray Loew; Narine Sarvazyan
Journal:  Biomed Opt Express       Date:  2018-04-16       Impact factor: 3.732

3.  Real-time optical spectroscopic monitoring of nonirrigated lesion progression within atrial and ventricular tissues.

Authors:  Rajinder P Singh-Moon; Xinwen Yao; Vivek Iyer; Charles Marboe; William Whang; Christine P Hendon
Journal:  J Biophotonics       Date:  2018-12-26       Impact factor: 3.207

4.  Autofluorescence hyperspectral imaging of radiofrequency ablation lesions in porcine cardiac tissue.

Authors:  Daniel A Gil; Luther M Swift; Huda Asfour; Narine Muselimyan; Marco A Mercader; Narine A Sarvazyan
Journal:  J Biophotonics       Date:  2016-08-22       Impact factor: 3.207

Review 5.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

6.  Anatomical and Optical Properties of Atrial Tissue: Search for a Suitable Animal Model.

Authors:  Narine Muselimyan; Mohammed Al Jishi; Huda Asfour; Luther Swift; Narine A Sarvazyan
Journal:  Cardiovasc Eng Technol       Date:  2017-09-07       Impact factor: 2.495

7.  Hyperspectral imaging for label-free in vivo identification of myocardial scars and sites of radiofrequency ablation lesions.

Authors:  Luther M Swift; Huda Asfour; Narine Muselimyan; Cinnamon Larson; Kenneth Armstrong; Narine A Sarvazyan
Journal:  Heart Rhythm       Date:  2017-12-12       Impact factor: 6.343

8.  Seeing the Invisible: Revealing Atrial Ablation Lesions Using Hyperspectral Imaging Approach.

Authors:  Narine Muselimyan; Luther M Swift; Huda Asfour; Tigran Chahbazian; Ramesh Mazhari; Marco A Mercader; Narine A Sarvazyan
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

Review 9.  Catheter Ablation of Atrial Fibrillation: A Review of the Current Status and Future Directions.

Authors:  Daniel P Melby
Journal:  J Innov Card Rhythm Manag       Date:  2017-11-15

10.  Key factors behind autofluorescence changes caused by ablation of cardiac tissue.

Authors:  Narine Muselimyan; Huda Asfour; Narine Sarvazyan
Journal:  Sci Rep       Date:  2020-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.